GOTHENBURG, Sweden and SAN FRANCISCO, Oct. 30, 2018 /PRNewswire/ --
Heliospectra AB (publ) (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from a leading medicinal plant research facility in Spain. The research facility is a privately-owned Spanish company founded in 2008 and active in the field of phytotherapy research. The order is for Heliospectra's fully adjustable ELIXIA LED lighting solution and valued at SEK 1.2 million (EUR € 117,855).
Heliospectra's ELIXIA creates clear business benefits for cultivation teams and researchers around the world. The fully adjustable LED lighting solution is compatible with Heliospectra's helioCORE™ light control software, enabling growers to improve the quality of plants and accelerate harvest and production cycles while providing consistent and standardized returns 365 days a year.
The order will be visible in the accounts and delivered in Q4 2018.
CEO of Heliospectra
Redeye is Heliospectra Certified Advisor for Nasdaq First North -www.redeye.se
This information was brought to you by Cision http://news.cision.com
The following files are available for download: